Stage
Series A | AliveTotal Raised
$14.8MLast Raised
$11.1M | 4 yrs agoAbout Inthera Bioscience
Inthera Bioscience, founded in 2013, employs a proprietary technology platform to rationally design protein-protein interaction inhibitors. The company has discovered disruptors of hypoxia-inducible signaling for the treatment of solid tumors and targeted agents against HPV- associated cancer, which are in pre-clinical development. Inthera Bioscience is a biopharmaceutical company focused on developing inhibitors of intracellular protein-protein interactions employing a proprietary technology platform.
Inthera Bioscience Headquarter Location
Einsiedlerstrasse 34
Waedenswil, 8820,
Switzerland
Latest Inthera Bioscience News
Jul 2, 2018
Inthera binds funding to series A round The cancer therapy developer has closed an $11.1m series A round featuring M Ventures and seed-stage backer Novo Seeds. Author: Callum Cyrus, Reporter Switzerland-based oncology therapy developer Inthera Bioscience has closed a series A round featuring subsidiaries of pharmaceutical firms Merck & Co and Novo at €9.6m ($11.1m). This rest of this content is only accessible to Global Corporate Venturing Subscribers This content is only accessible to subscribers. If you are a subscriber,please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
Expert Collections containing Inthera Bioscience
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Inthera Bioscience is included in 4 Expert Collections, including Pharma Startups.
Pharma Startups
6,549 items
Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.
Cancer Therapeutics
1,179 items
Pharmaceutical and biotechnology companies with cancer therapy drug candidates.
Cancer
3,604 items
Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.
Digital Health
11,220 items
Companies leveraging digital technology for healthcare, consumer health, clinical research, and life science (e.g. biopharma, medtech) applications.
Inthera Bioscience Patents
Inthera Bioscience has filed 2 patents.
The 3 most popular patent topics include:
- Sedatives
- Stereochemistry
- Hypnotics
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
12/17/2018 | 7/14/2020 | Small nuclear RNA, V8SuperTourer drivers, Stereochemistry, Trifluoromethyl compounds, Sedatives | Grant | |
Application Date | 12/17/2018 | |
|---|---|---|
Grant Date | 7/14/2020 | |
Title | ||
Related Topics | Small nuclear RNA, V8SuperTourer drivers, Stereochemistry, Trifluoromethyl compounds, Sedatives | |
Status | Grant |
